![PE134010: β-GalNAc-PEG3-Azide label-new HCl / N-[2-Butyl-3-[4-[3-(butylamino)propoxybenzoyl]-5-benzofuranyl]-methanesulfonamide-d6 Hydrochloride](https://cdn.shopify.com/s/files/1/0810/4889/5786/files/PE134010-R_f8bae31b-2c31-46c0-8ea1-611f9226bf78.svg?v=1700577073)
Pay in 4 interest-free payments of $56.25 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
HCl / N-[2-Butyl-3-[4-[3-(butylamino)propoxybenzoyl]-5-benzofuranyl]-methanesulfonamide-d6 Hydrochloride
HSV-1 uses this glycopeptide ligand to bind paired immunoglobulin-like type 2 receptor α (PILRα) on immune cells
enabling enzymatic chain extension
C17H30N4O11 / 466
PE134010: β-GalNAc-PEG3-Azide label-new HCl / N-[2-Butyl-3-[4-[3-(butylamino)propoxybenzoyl]-5-benzofuranyl]-methanesulfonamide-d6 HydrochlorideC14H26N4O9 378. 38 A D N acetylgalactosamine (GalNAc) ligand equipped with an azide handle through a hydrophilic PEG3 spacer. The terminal azide couples to alkynes via copper catalyzed azide alkyne cycloaddition (CuAAC) or to DBCO and related strained alkynes via copper free click chemistry, forming stable 1,2,3 triazole linkages. This compound enables the construction of hepatocyte targeted therapeutics and research tools that exploit the
